Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
Cell Host & Microbe · 2024-08 · 32 (8) · 1380-1393.e9
DOI: 10.1016/j.chom.2024.06.010 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Cell Host & Microbe, 2024-08. Verfasst von Yunjae Kim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Gastrointestinal Microbiome, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 220-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Cancer Center, Asan Institute for Life Sciences, Asan Medical Center, Gwangju Institute of Science and Technology.
Abstract (Originalsprache)
The gut microbiome significantly influences immune responses and the efficacy of immune checkpoint inhibitors. We conducted a clinical trial (NCT04264975) combining an anti-programmed death-1 (PD-1) inhibitor with fecal microbiota transplantation (FMT) from anti-PD-1 responder in 13 patients with anti-PD-1-refractory advanced solid cancers. FMT induced sustained microbiota changes and clinical benefits in 6 of 13 patients, with 1 partial response and 5 stable diseases, achieving an objective response rate of 7.7% and a disease control rate of 46.2%. The clinical response correlates with increased cytotoxic T cells and immune cytokines in blood and tumors. We isolated Prevotella merdae Immunoactis from a responder to FMT, which stimulates T cell activity and suppresses tumor growth in mice by enhancing cytotoxic T cell infiltration. Additionally, we found Lactobacillus salivarius and Bacteroides plebeius may inhibit anti-tumor immunity. Our findings suggest that FMT with beneficial microbiota can overcome resistance to anti-PD-1 inhibitors in advanced solid cancers, especially gastrointestinal cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea; Genome and Company, Suwon-si 16229, Gyeonggi-do, Republic of Korea.
- Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
- PrismCDX Co., Ltd., Hwaseong-si 18469, Gyeonggi-do, Republic of Korea.
- Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Förderung
- National Cancer Center
- Asan Institute for Life Sciences, Asan Medical Center
- Gwangju Institute of Science and Technology
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Kim, Y., Kim, G., Kim, S., Cho, B., Kim, S. Y., Do, E. J., Bae, D. J., Kim, S., Kweon, M. N., Song, J. S., Park, S. H., Hwang, S. W., Kim, M. N., Kim, Y., Min, K., Kim, S. H., Adams, M. D., Lee, C., Park, H., & Park, S. R. (2024). Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor. Cell Host & Microbe, 32(8), 1380-1393.e9. https://doi.org/10.1016/j.chom.2024.06.010
Vancouver
Kim Y, Kim G, Kim S, Cho B, Kim SY, Do EJ, et al. Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor. Cell Host & Microbe. 2024;32(8):1380-1393.e9. doi:10.1016/j.chom.2024.06.010
BibTeX
@article{Kim2024,
author = {Kim, Yunjae and Kim, Gihyeon and Kim, Sujeong and Cho, Beomki and Kim, Sang-Yeob and Do, Eun-Ju and Bae, Dong-Jun and Kim, Seungil and Kweon, Mi-Na and Song, Joon Seon and Park, Sang Hyoung and Hwang, Sung Wook and Kim, Mi-Na and Kim, Yeongmin and Min, Kyungchan and Kim, Sung-Han and Adams, Mark D and Lee, Charles and Park, Hansoo and Park, Sook Ryun},
title = {Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor},
journal = {Cell Host & Microbe},
year = {2024},
volume = {32},
number = {8},
pages = {1380--1393.e9},
doi = {10.1016/j.chom.2024.06.010}
}
EUVIMED